Psoriasiform lesions as a side effect of SGLT-2 therapy

• Main Authors: Jakub Krzysztof Gałązka (Author), Łukasz Domagalski (Author), Piotr Homa (Author), Zofia Hoffman (Author)
• Format: Book
• Published: Nicolaus Copernicus University in Toruń, 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

SGLT-2 inhibitors (flozins) are one of the new classes of anti-diabetic drugs, used from 2012. They are highly recommended in case of intolerance or contraindication of metformin, but in Poland they are used usually as third-line drug after metformin and sulfonylurea. They growing popularity is caus...